 MELBOURNE, Australia, Dec. 06, 2022 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT; NASDAQ:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announce a podium talk will be presented at the annual FLORetina congress, taking place in Rome, Italy from December 8-11, 2022. 